MondayOct 16, 2017 11:40 am

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 16, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: RCON 140.70% – News: Inks three-year strategic cooperation agreement with BOW Engineering LBIX 35.68% – News: Posts Q2 2017 financial results ARQL 11.35% – News: Closes $15.7M private placement CLSN 7.35% – News: HEAT study highlighted in Clinical Cancer Research publication ETRM 7.22% – News: Presenting at ObesityWeek 2017 October 29 to November 2 SVON 6.34% – News: Receives new European patent covering ELX-02 SNYR 4.35% – News: Names new chief financial officer UTSI 4.28%…

Continue Reading

MondayOct 16, 2017 11:37 am

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Receives Reiterated “Buy” Rating at Mizuho Securities

Mizuho Securities USA LLC has reiterated its ‘Buy’ rating and price target of $70 on shares of Aerie Pharmaceuticals, Inc.’s (NASDAQ: AERI) stock following the FDA's Dermatologic and Ophthalmic Drug Advisory Committee vote in favor of Rhopressa. The committee’s decision regarded two key points: efficacy for reducing intraocular pressures (IOP) and efficacy outweighing safety risks. First, the committee voted 10-0 when asked if the clinical trials support Rhopressa's efficacy for reducing elevated IOP for patients with open-angle glaucoma or ocular hypertension. The second question posed to the committee asked if the identified safety risks were outweighed by the efficacy demonstrated…

Continue Reading

MondayOct 16, 2017 11:33 am

NetworkNewsBreaks – Aethlon Medical, Inc. (NASDAQ: AEMD) Establishes Large-Scale Production Collaboration with iBio, Inc. (NYSE: IBIO)

Aethlon Medical (NASDAQ: AEMD) this morning said that it has established a collaboration with iBio, Inc. (NYSE AMERICAN: IBIO) to support potential large-scale production of the Aethlon Hemopurifier®. The companies intend to advance large-scale production of a recombinant form of Galanthus nivalis agglutinin (GNA), a plant-derived lectin that is immobilized within the Hemopurifier® to bind infectious enveloped viruses. Aethlon has completed a feasibility study with iBio researchers confirming the capability to produce highly active recombinant GNA through the use of iBio's plant-based technology. "The production of recombinant GNA in iBio's large-scale manufacturing facilities establishes a pathway for us to access…

Continue Reading

MondayOct 16, 2017 9:41 am

NetworkNewsBreaks – MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) Announces Advancement in Magnesium Extraction

Diversified resource and technology company MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF), alongside engineering partner PurLucid Treatment Solutions, this morning announced its recent advancement in magnesium extraction. The optimization focused on addressing complex brines with very high magnesium levels, as well as extraction to a common marketable form of magnesium compound. “Magnesium in brine, often referred to as hardness in water, has traditionally been one of the major issues in processing of lithium concentrate,” Jared Lazerson, CEO of MGX Minerals, stated in the news release. “Removal of very high levels of magnesium opens up a large number of…

Continue Reading

MondayOct 16, 2017 9:10 am

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Makes Successful Showing at 2017 Southwest Cannabis Conference and Expo

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that MoneyTrac Technology, Inc., its majority-owned subsidiary, in addition to its newly-acquired marketing and publishing entity, PotSaver, made a successful showing at last week’s Southwest Cannabis Conference and Expo in Phoenix, Arizona. “Attending this event was an excellent opportunity for us to share the vast array of technology and business-related solutions MoneyTrac has to offer to the many new and existing businesses in cannabis,” James Hancock, CEO of MoneyTrac, stated in the news release. “In having had the chance to speak with several different owners of these businesses, it…

Continue Reading

FridayOct 13, 2017 1:04 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 13, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: MARK 20.91% – News: Provides core technology for Sina Weibo's new mobile application GLAE 7.01% – News: Added to the OTCQX composite index LFVN 3.81% – News: Held its annual European Leadership Academy on October 8 MSDI 2.71% – News: Changes the date of its Special Meeting of Stockholders to November 9 AMNF 2.69% – News: Posts highlights from Q3 2017 ONCS 2.50% – News: Hosting its fiscal Q4, FY 2017 financial results conference…

Continue Reading

FridayOct 13, 2017 1:00 pm

NetworkNewsBreaks – Quarterhill, Inc. (NASDAQ: QTRH) Hits New 52-Week High after Subsidiary Acquires Patent Portfolio

Wi-LAN, a Quarterhill (NASDAQ: QTRH) company, this morning said that its wholly owned SecureWave Storage Solutions, Inc. subsidiary has acquired a portfolio of patents from Wave Systems Corp. The patents cover various technologies including improvements to securing data for storage devices, such as self-encrypting drives. These enhancements prevent unauthorized access to data at the storage device level in client devices, data centers, and servers. Following the news, shares of Quarterhill reached a new 52-week high, currently trading at $1.79. To view the full press release, visit: http://nnw.fm/1wWU1 About WiLAN WiLAN, a Quarterhill company, is a global patent licensing company. The…

Continue Reading

FridayOct 13, 2017 11:32 am

NetworkNewsBreaks – International Endeavors Corp. (IDVV) Enters MOU with Kubby Cryogenics, Inc. to Expand Medical Cannabis Line

International Endeavors (OTC: IDVV) this morning said that it has signed a memorandum of understanding (MOU) with Kubby Cryogenics, Inc. Per the agreement, Kubby Cryogenics will seek to patent medical grade cannabis strains that are genetically profiled to treat specific diseases. The agreement also states that Steve Kubby will immediately become CEO of International Endeavors. Kubby Cryogenics has assembled a team of top scientists and geneticists to continue developing the company’s proprietary cryogenics products. "We will create a dispensary system for legal medical cannabis states standardizing the patient centered, consultation approach while presenting an enticing line of Adult Use products…

Continue Reading

FridayOct 13, 2017 11:29 am

NetworkNewsBreaks – PhaseRx, Inc. (NASDAQ: PZRX) Initiates Corporate Restructuring, Review of Strategic Alternatives

Shares of PhaseRx (NASDAQ: PZRX) are up 43.5% after the company this morning said that its board of directors has decided to conduct a restructuring of operations in an effort to decrease short term operating expenses and delay the development of its lead product candidate, PRX-OTC. In an effort to preserve the company’s cash resources, the restructuring includes a decrease in PhaseRx's personnel by 10 employees, including some executive officers. As of June 30, 2017, PhaseRx had cash and equivalents of $8.4 million and a total of 20 employees. The company’s board of directors has also started a review of strategic alternatives, such as…

Continue Reading

FridayOct 13, 2017 11:10 am

NetworkNewsBreaks – India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s

India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease (http://nnw.fm/l2NJw). IGC is engineering genetic cell lines which demonstrate that, at various concentrations of tetrahydrocannabinol (THC), the protein Aβ decreases as much as 40 percent without neuron damage. An article discussing this reads: “This compelling in vitro data, and the promise it shows as a preventative and powerful treatment against Alzheimer’s, makes IGC a company with valuation growth potential for investors. The commercial potential for an Alzheimer’s treatment…

Continue Reading

Contact us: 212.418.1217